Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1989 1
1990 2
1991 3
1992 2
1993 4
1994 7
1995 6
1996 5
1997 2
1998 1
1999 3
2000 5
2001 2
2002 5
2003 1
2004 5
2005 6
2006 6
2007 11
2008 11
2009 8
2010 13
2011 12
2012 11
2013 19
2014 25
2015 15
2016 11
2017 13
2018 10
2019 9
2020 11
2021 8
2022 11
2023 12

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Ogbuagu O, Ruane PJ, Podzamczer D, Salazar LC, Henry K, Asmuth DM, Wohl D, Gilson R, Shao Y, Ebrahimi R, Cox S, Kintu A, Carter C, Das M, Baeten JM, Brainard DM, Whitlock G, Brunetta JM, Kronborg G, Spinner CD; DISCOVER study team. Ogbuagu O, et al. Lancet HIV. 2021 Jul;8(7):e397-e407. doi: 10.1016/S2352-3018(21)00071-0. Lancet HIV. 2021. PMID: 34197772 Clinical Trial.
BACKGROUND: In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mineral density and renal safety b …
BACKGROUND: In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine a …
Stolperstart für den neuen Infektiologie-Facharzt.
Bickel M. Bickel M. MMW Fortschr Med. 2023 Jun;165(Suppl 2):29-30. doi: 10.1007/s15006-023-2650-4. MMW Fortschr Med. 2023. PMID: 37249851 Free PMC article. German. No abstract available.
HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.
Renelt S, Schult-Dietrich P, Baldauf HM, Stein S, Kann G, Bickel M, Kielland-Kaisen U, Bonig H, Marschalek R, Rieger MA, Dietrich U, Duerr R. Renelt S, et al. Among authors: bickel m. Cells. 2022 Sep 23;11(19):2968. doi: 10.3390/cells11192968. Cells. 2022. PMID: 36230931 Free PMC article.
Latent reservoirs in human-immunodeficiency-virus-1 (HIV-1)-infected individuals represent a major obstacle in finding a cure for HIV-1. Hematopoietic stem and progenitor cells (HSPCs) have been described as potential HIV-1 targets, but their roles as HIV …
Latent reservoirs in human-immunodeficiency-virus-1 (HIV-1)-infected individuals represent a major obstacle in finding a cure for …
Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation.
Kann G, Wetzstein N, Bielke H, Schuettfort G, Haberl AE, Wolf T, Kuepper-Tetzel CP, Wieters I, Kessel J, de Leuw P, Bickel M, Khaykin P, Stephan C. Kann G, et al. Among authors: bickel m. J Infect. 2021 Sep;83(3):347-353. doi: 10.1016/j.jinf.2021.06.027. Epub 2021 Jul 7. J Infect. 2021. PMID: 34242683
BACKGROUND: HIV-infected patients with Pneumocystis-pneumonia (PCP) may develop paradoxical immune reconstitution inflammatory syndrome (IRIS), when combination antiretroviral therapy (cART) is started early during the course of PCP-treatment (PCPT). ...METHODS: An ICD-10 …
BACKGROUND: HIV-infected patients with Pneumocystis-pneumonia (PCP) may develop paradoxical immune reconstitution inflammatory syndro …
Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine.
Vasylyev M, Skrzat-Klapaczyńska A, Bernardino JI, Săndulescu O, Gilles C, Libois A, Curran A, Spinner CD, Rowley D, Bickel M, Aichelburg MC, Nozza S, Wensing A, Barber TJ, Waters L, Jordans C, Bramer W, Lakatos B, Tovba L, Koval T, Kyrychenko T, Dumchev K, Buhiichyk V, Smyrnov P, Antonyak S, Antoniak S, Vasylyeva TI, Mazhnaya A, Kowalska J, Bhagani S, Rokx C; European AIDS Clinical Society (EACS) Young Investigators (YING). Vasylyev M, et al. Among authors: bickel m. Lancet HIV. 2022 Jun;9(6):e438-e448. doi: 10.1016/S2352-3018(22)00125-4. Epub 2022 May 13. Lancet HIV. 2022. PMID: 35576942 Review.
Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war on the European continent has affected HIV care in Ukraine in an unprecedented way. ...Through a rapid literature review we identified the key strategies needed to create a su …
Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war on the European continent has affected …
Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection.
van Bremen K, Hoffmann C, Mauss S, Lutz T, Ingiliz P, Spinner CD, Scholten S, Schwarze-Zander C, Berger F, Breitschwerdt S, Schneeweiss S, Busch F, Wasmuth JC, Fätkenheuer G, Lehmann C, Rockstroh JK, Boesecke C. van Bremen K, et al. Among authors: lutz t. Liver Int. 2020 Dec;40(12):2978-2981. doi: 10.1111/liv.14684. Epub 2020 Oct 14. Liver Int. 2020. PMID: 33012099
Several cohorts have shown that long-term tenofovir-containing combination antiretroviral therapy (cART) leads to higher HBsAg seroclearance rates in HIV/HBV coinfected patients vs HBV-monoinfected patients under tenofovir disoproxil fumarate (TDF)-based ther …
Several cohorts have shown that long-term tenofovir-containing combination antiretroviral therapy (cART) leads to higher HBsAg seroclearance …
Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis.
Wolf T, Fuß B, Khaykin P, Berger A, Knecht G, Gute P, Brodt HR, Goepel S, Bickel M, Stuermer M, Stephan C; Frankfurt HIV Cohort Study. Wolf T, et al. Among authors: gute p, bickel m, knecht g. Med Microbiol Immunol. 2014 Dec;203(6):409-14. doi: 10.1007/s00430-014-0350-5. Epub 2014 Aug 23. Med Microbiol Immunol. 2014. PMID: 25148909 Free PMC article.
To evaluate the treatment outcome of antiretroviral therapy, depending on the use and utility of a concept of resistance-guided switch, patients from the Frankfurt HIV cohort have been followed for 24 weeks. If available, prior resistance data have been evaluated an …
To evaluate the treatment outcome of antiretroviral therapy, depending on the use and utility of a concept of resistance-guided switch, pati …
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study.
Hentrich MU, Bower M, Daugaard G, Dieing A, Bickel M, Berretta M, Lesmeister F, Jurinovic V, Stoehr A, Heinzelbecker J, Krznaric I, Dieckmann KP, Necchi A, Maroto Rey P, Rockstroh JK, Brito M, Pfister D, Hoffmann C. Hentrich MU, et al. Among authors: bickel m. Cancer. 2022 Jan 15;128(2):260-268. doi: 10.1002/cncr.33928. Epub 2021 Sep 30. Cancer. 2022. PMID: 34592009 Free article.
Patients with HIV-GCC should be managed identically to HIV-negative patients. ...Patients with HIV-GCC should be managed identically to HIV-negative patients....
Patients with HIV-GCC should be managed identically to HIV-negative patients. ...Patients with HIV-GCC should be manage …
[HIV First Diagnoses in Germany in 2014 - A Regional Analysis].
Thomas Schleenvoigt B, Ankert J, Stocker H, Stoehr A, Lehmann C, Schulz C, Wesselmann H, Bickel M, Haberl A, Degen O, Pletz MW, Seybold U, Stephan C; für die HIV-Regional Studiengruppe; HIV-regional Studiengruppe Axel Baumgarten, Christoph Boesecke, Carlos Fritzsche, Thomas Heuchel, Stefanie Holm, Andreas Jenke, Heribert Knechten, Christoph Lübbert, Rainer Lundershausen, Anja Meurer, Ramona Pauli, Nils Postel, Katja Römer, Steve Rößler, Ines Ruck, Thomas Seidel, Markus Sellmann, Matthias Stoll, Christoph Spinner, Petra Spornraft-Ragaller, Michael Waizmann, Eva Wolf, Christoph Wyen. Thomas Schleenvoigt B, et al. Among authors: bickel m. Gesundheitswesen. 2022 Nov;84(11):e45-e52. doi: 10.1055/a-1665-6762. Epub 2022 Feb 17. Gesundheitswesen. 2022. PMID: 35176792 German.
A regional comparison revealed that in eastern Germany, for first diagnosed HIV-patients were younger, had a higher HIV-RNA viral load and also more often clinical AIDS. CONCLUSION: This analysis of HIV-Regional for 2014 enables a deeper insight into HIV …
A regional comparison revealed that in eastern Germany, for first diagnosed HIV-patients were younger, had a higher HIV-RNA vi …
247 results